Author

K. Ohmura

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Nakagawa· 2 shared C. Ono· 2 shared H. Arase· 2 shared K. Tomii· 2 shared M. Kohyama· 2 shared M. Okada· 2 shared S. Matsuoka· 2 shared W. Nakai· 2 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Nakagawa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivAug 1, 2022

SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses

M. Kohyama, T. Suzuki, W. Nakai…·H. Arase

This study shows that SARS-CoV-2 ORF8 protein acts as a cytokine that promotes lung inflammation and immune dysregulation in COVID-19, suggesting it as a potential therapeutic target.

DOI 10.1093/intimm/dxac044

mouseproteomics

𝕏 PostBluesky

MicrobiologybioRxivDec 18, 2020

An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies

Y. Liu, W. T. Soh, A. Tada…·H. Arase

This study identifies an NTD site on SARS-CoV-2 spike protein that enhances infectivity when targeted by antibodies, and finds these antibodies are present in hospitalized patients and some uninfected donors.

DOI 10.1016/j.cell.2021.05.032

humanproteomics

𝕏 PostBluesky